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Abstract
Q fever endocarditis is a chronic disease with protean manifestations. The clinical and serological manifestations of nine patients diag-
nosed as having Q fever endocarditis during a 19-year period are reviewed. Four patients (44%) required valve replacement due to
congestive heart failure. Three of these four patients were diagnosed as having Q fever endocarditis only after elective valve surgery, by
histopathological examination of the valve and subsequent serological tests. Prior to surgery they were afebrile and had no other symp-
tom or sign indicative of endocarditis. The antibiotic treatment and the decreasing titres of Q fever antibodies of all nine patients during
several years of follow-up are summarized. Careful assessment of heart valves for histopathological evidence of inflammation is
suggested, even after elective replacement. If found, clinical and laboratory evaluation should include determination of anti-Coxiella
burnetti antibodies.
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Introduction
Q fever is a zoonosis caused by Coxiella burnetii, and endo-
carditis is its most common chronic manifestation. Although
Q fever endocarditis is a rare disease, C. burnetii is an impor-
tant cause of culture-negative endocarditis. Onset is usually
insidious and manifestations are protean: low-grade fever,
fatigue and weight loss [1]; it even occurs as an asymptom-
atic disease, diagnosed by PCR [2] or serological testing
postoperatively [3], often leading to delayed diagnosis and a
high rate of mortality. The purpose of this report is to
describe the relative incidence of unexpected Q fever endo-
carditis, diagnosed after elective valve surgery.
Patients and Methods
The study was performed in a 550-bed university-affiliated
general hospital in Jerusalem, Israel. We conducted a
retrospective review of all records of patients diagnosed
with Q fever endocarditis during a 19-year period (January
1989–2008). The diagnosis of Q fever endocarditis was made
using the modified Duke criteria, which include an antiphase
I IgG antibody titre of ‡1:800, transoesophageal echocardio-
graphic and/or histopathological findings of a valve consistent
with endocarditis as major criterion [4]. An indirect immu-
nofluorescent antibody test was used to determine titres of
IgG and IgM against phase I and phase II C. burnetii antigens.
Clinical and laboratory data were retrieved from the
patients’ records.
Results
From 1989 to 2008, nine patients were diagnosed with Q
fever endocarditis or endovascular infection (Table 1). Eight
patients (89%) were male and their mean age was 54 years
(range 39–78). Eight patients had known risk factors for
endocarditis/endovascular infection, such as pre-existing
valvular disease, a prosthetic valve or a vascular graft. Six
patients (67%) had fever as the presenting manifestation,
whereas five had symptoms consistent with heart failure. In
six patients the diagnosis was delayed for 1 month or more
from the onset of symptoms. Three patients (33%) (nos 1, 5
and 7) were diagnosed after valve replacement by routine
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histopathology showing acute inflammation and by subse-
quent serological tests, but they had no fever or other
constitutional or inflammatory symptoms prior to surgery.
Gross examination of the valves of two patients (1 and 5)
was unremarkable; however, histological examination
revealed fibrotic and calcified valves and fibrinous vegetations
with a neutrophilic infiltrate. The histopathological results of
the biological valve of patient 7 demonstrated necrosis, fibri-
noid thrombus, calcifications and foci of acute inflammatory
infiltrate. Only three patients presented with an acute/sub-
acute disease that had lasted 1–2 weeks. One patient (no. 6)
was diagnosed as having endovascular infection with chronic
Q fever, presumably involving his abdominal aortic graft, as
his heart valves were entirely normal. Only four patients
(44%) had significant anaemia (haemoglobin <12 g/dL) at
diagnosis; and six of the seven available erythrocyte sedimen-
tation rate (ESR) test results were elevated (Table 1).
All patients were treated with oral antibiotics for Q fever
endocarditis for years, or are presently receiving antibiotic
treatment, according to the preferred regimen at the time of
diagnosis. Five patients (56%) underwent valve replacement
at some stage following diagnosis of Q fever endocarditis.
There was no mortality attributable to endocarditis.
The serological tests (Table 2) showed decreasing anti-
phase I IgG antibody titres in six patients, in most of whom
the reduction was of the order of three twofold dilutions.
Two patients have consistently increasing IgG titres, although
one of them remains asymptomatic and has therapeutic
blood levels of doxycycline and hydroxychloroquine.
Discussion
Coxiella burnetii is an obligatory intracellular organism, causing
a zoonotic disease with various manifestations. Q fever may
be asymptomatic or cause acute or chronic illness. Acute
infection usually presents as an influenza-like illness, pneumo-
nia, hepatitis or, rarely, myocarditis. Chronic disease can
occur months or even years after acute illness [5], or follow-
ing asymptomatic infection. Endocarditis accounts for 60–70%
of patients with chronic Q fever [6] and manifestations are
often atypical: patients are often afebrile, vegetations are
usually absent or small and there is a long interval between
onset and diagnosis [7]. The disease causes substantial mor-
bidity and often requires surgical intervention and prolonged
antimicrobial therapy. A high level of suspicion is required to
diagnose Q fever endocarditis, and all patients with culture-
negative endocarditis should be tested for Q fever.
An unexpected inflammatory infiltrate in heart valves of
patients undergoing elective valve surgery for reasons other
than endocarditis was found at a rate of 0.9% (eight of 857
patients) in a previous study from our hospital [8], one of
whom had positive Q fever serology. In order to determine
the relative incidence of latent infective endocarditis caused
by C. burnetii, we retrospectively reviewed the records of
patients in our hospital with the diagnosis of Q fever endo-
carditis. Nine patients were diagnosed with this disease
during the years 1989–2008. Records of the original hospital
admissions and follow-up visits were reviewed. Three of nine
(33%) patients with Q fever endocarditis were unexpected
and diagnosed only after elective surgery for reasons other
than endocarditis. All three patients reported here, who
were diagnosed after surgery, had symptoms of congestive
heart failure during several months before operation and did
not have a history of a febrile disease. The small number of
cases does not allow for statistical analysis of the differences
between patients recognized before or after valve surgery.
A recent case report [9] described a 53-year-old patient
with a prosthetic aortic valve who was diagnosed with blood
culture-negative endocarditis. This patient was eventually
diagnosed retrospectively as suffering from Q fever endocar-
ditis, similar to the three patients in our report.
TABLE 2. Serological results of patients with Q fever endocarditis/endovascular infection at diagnosis and during follow-up
Patient
Diagnosis Follow-up visit Most recent follow-up
IgM IgG IgM IgG IgM IgG
Phase I Phase II Phase I Phase II Phase I Phase II Phase I Phase II Phase I Phase II Phase I Phase II
1 NA NA NA NA <1:20 <1:20 1:3200 1:3200 <1:20 <1:20 1:400 1:800
2 NA NA >1:32 000 1:4,000 <1:20 <1:20 1:1600 1:400 <1:20 <1:20 1:800 1:800
3 <1:20 <1:20 1:6,400 1:25 600 <1:20 <1:20 1:3200 1:3200 <1:20 <1:20 1:1600 1:6400
4 >1:6400 1:1600 >1:6400 >1:6 400 NA NA NA NA 1:20 1:20 1:800 1:1600
5 1:20 1:20 >1:32 000 1:8000 <1:20 <1:20 1:800 1:1600 <1:20 <1:20 1:3200 1:1600
6 1:20 1:20 >1:6,400 1:1600 <1:20 <1:20 >1:25 600 1:3200 <1:20 <1:20 1:51 200 1:25 600
7 <1:20 <1:20 1:51 200 1:25 600 <1:20 <1:20 1:51 200 1:51 200 <1:20 <1:20 1:102 400 1:102 400
8 1:3200 1:1600 1:32 000 1:16 000 1:1600 1:400 1:16 000 1:16 000 1:200 1:200 1:6400 1:12 800
9 1:800 1:400 1:1 024 000 1:1 024 000
Patients 8–9 were diagnosed recently and follow-up was therefore short.
NA, not available.
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Another diagnostic method making use of paraffin-embed-
ded heart valves for the detection of infective endocarditis,
especially of cases due to rare and fastidious bacteria such as
C. burnetii, is DNA amplification by PCR. Sequencing of 16S
rRNA-encoding DNA extracted from cardiac valve tissue
may be useful when endocarditis is unsuspected but
suggested by histopathological examination after valve
replacement [10,11].
In summary, we report on nine patients with Q fever
endocarditis during a 19-year period, three (33%) of whom
were unexpected and diagnosed after elective valve surgery.
We believe that events like these are not as rare as previ-
ously thought and that they are probably underdiagnosed
due to the protean manifestations of Q fever endocarditis.
Careful clinical assessment is called for to rule out endo-
carditis in patients scheduled for elective valve surgery.
Evidence of endocarditis should be looked for prior to
elective valve replacement, regardless of the indication for
operation. ESRs, and possibly C-reactive protein levels,
should be determined as non-specific, but sensitive indicators
of inflammation, and, if pathological, work-up should be done
before valve replacement. All removed valves should be sent
for histological examination and, if an inflammatory infiltrate
is detected, serological tests for C. burnetii and other
pathogens should be carried out.
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